DENTSPLY SIRONA (XRAY) EVP granted 829.396 phantom stock units

Rhea-AI Filing Summary

Denti Aldo Mariano Roberto reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. executive Aldo Mariano Roberto Denti, EVP and Chief Commercial Officer, received an award of 829.396 shares of phantom stock under the company’s Supplemental Executive Retirement Plan for 2025, based on the 12/31/25 closing price. Each phantom share is economically equivalent to one share of common stock and becomes payable in common stock when his employment terminates. After this grant, his reported phantom stock balance is 829.396 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Denti Aldo Mariano Roberto

Role EVP, Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (Supplemental Executive Retirement Plan) SERP	829.396	$11.43	$9K

Holdings After Transaction: Phantom Stock (Supplemental Executive Retirement Plan) SERP — 829.396 shares (Direct)

Footnotes (1)

1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. Comprised of phantom stock. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Denti Aldo Mariano Roberto

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(1)	03/11/2026		A		829.396(2)		(1)	(1)	Common Stock	829.396	$11.43(3)	829.396	D

Explanation of Responses:

1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

2. Comprised of phantom stock.

3. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Aldo Mariano Roberto Denti	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Aldo Denti?

DENTSPLY SIRONA reported that EVP and Chief Commercial Officer Aldo Denti received 829.396 phantom stock shares. These were credited under the Supplemental Executive Retirement Plan for 2025 and are tied to the 12/31/25 closing price, functioning as deferred stock-based compensation.

What is the nature of the phantom stock granted to the XRAY executive?

The phantom stock granted to the XRAY executive is the economic equivalent of common stock. Each phantom share tracks one common share’s value and will be settled in actual common stock when the executive’s employment ends, providing deferred equity-linked retirement benefits.

How many phantom stock units does the XRAY EVP hold after this Form 4?

After this Form 4 transaction, the XRAY EVP holds 829.396 phantom stock units. The entire reported position comes from this grant, which is classified as a grant, award, or other acquisition rather than an open-market purchase or sale of common shares.

Is the DENTSPLY SIRONA (XRAY) Form 4 an open-market stock trade?

No, the DENTSPLY SIRONA Form 4 reflects a grant of 829.396 phantom stock units, not an open-market trade. The award arises from the Supplemental Executive Retirement Plan and will be paid in common stock only when the executive’s employment terminates.

How is the XRAY Supplemental Executive Retirement Plan contribution calculated?

The XRAY Supplemental Executive Retirement Plan contribution for this executive is based on the 12/31/25 closing price. That price determined how many phantom stock units, 829.396 in total, were credited for the 2025 plan year as deferred equity-based retirement compensation.